The global Iguratimod market size was valued at US$ 156.2 million in 2024 and is projected to reach US$ 234.7 million by 2030, at a CAGR of 7.0% during the forecast period 2024-2030.
United States Iguratimod market size was valued at US$ 8.4 million in 2024 and is projected to reach US$ 13.6 million by 2030, at a CAGR of 8.4% during the forecast period 2024-2030.
Iguratimod is a disease-modifying antirheumatic drug (DMARD) used in the treatment of rheumatoid arthritis.
Growth driven by increasing prevalence of rheumatoid arthritis. Limited approval in major markets constraining global size. Potential for expanded indications and geographic reach boosting future prospects.
Report Overview
This report provides a deep insight into the global Iguratimod market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Iguratimod Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Iguratimod market in any manner.
Global Iguratimod Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Simcere Pharmaceutical
- Toyama Chemical
- Eisai
Market Segmentation (by Type)
Market Segmentation (by Application)
- Antirheumatic
- Immunoregulation
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Iguratimod Market
- Overview of the regional outlook of the Iguratimod Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Iguratimod
1.2 Key Market Segments
1.2.1 Iguratimod Segment by Type
1.2.2 Iguratimod Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Iguratimod Market Overview
2.1 Global Market Overview
2.1.1 Global Iguratimod Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Iguratimod Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Iguratimod Market Competitive Landscape
3.1 Global Iguratimod Sales by Manufacturers (2019-2024)
3.2 Global Iguratimod Revenue Market Share by Manufacturers (2019-2024)
3.3 Iguratimod Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Iguratimod Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Iguratimod Sales Sites, Area Served, Product Type
3.6 Iguratimod Market Competitive Situation and Trends
3.6.1 Iguratimod Market Concentration Rate
3.6.2 Global 5 and 10 Largest Iguratimod Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Iguratimod Industry Chain Analysis
4.1 Iguratimod Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Iguratimod Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Iguratimod Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Iguratimod Sales Market Share by Type (2019-2024)
6.3 Global Iguratimod Market Size Market Share by Type (2019-2024)
6.4 Global Iguratimod Price by Type (2019-2024)
7 Iguratimod Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Iguratimod Market Sales by Application (2019-2024)
7.3 Global Iguratimod Market Size (M USD) by Application (2019-2024)
7.4 Global Iguratimod Sales Growth Rate by Application (2019-2024)
8 Iguratimod Market Segmentation by Region
8.1 Global Iguratimod Sales by Region
8.1.1 Global Iguratimod Sales by Region
8.1.2 Global Iguratimod Sales Market Share by Region
8.2 North America
8.2.1 North America Iguratimod Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Iguratimod Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Iguratimod Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Iguratimod Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Iguratimod Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Simcere Pharmaceutical
9.1.1 Simcere Pharmaceutical Iguratimod Basic Information
9.1.2 Simcere Pharmaceutical Iguratimod Product Overview
9.1.3 Simcere Pharmaceutical Iguratimod Product Market Performance
9.1.4 Simcere Pharmaceutical Business Overview
9.1.5 Simcere Pharmaceutical Iguratimod SWOT Analysis
9.1.6 Simcere Pharmaceutical Recent Developments
9.2 Toyama Chemical
9.2.1 Toyama Chemical Iguratimod Basic Information
9.2.2 Toyama Chemical Iguratimod Product Overview
9.2.3 Toyama Chemical Iguratimod Product Market Performance
9.2.4 Toyama Chemical Business Overview
9.2.5 Toyama Chemical Iguratimod SWOT Analysis
9.2.6 Toyama Chemical Recent Developments
9.3 Eisai
9.3.1 Eisai Iguratimod Basic Information
9.3.2 Eisai Iguratimod Product Overview
9.3.3 Eisai Iguratimod Product Market Performance
9.3.4 Eisai Iguratimod SWOT Analysis
9.3.5 Eisai Business Overview
9.3.6 Eisai Recent Developments
10 Iguratimod Market Forecast by Region
10.1 Global Iguratimod Market Size Forecast
10.2 Global Iguratimod Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Iguratimod Market Size Forecast by Country
10.2.3 Asia Pacific Iguratimod Market Size Forecast by Region
10.2.4 South America Iguratimod Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Iguratimod by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Iguratimod Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Iguratimod by Type (2025-2030)
11.1.2 Global Iguratimod Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Iguratimod by Type (2025-2030)
11.2 Global Iguratimod Market Forecast by Application (2025-2030)
11.2.1 Global Iguratimod Sales (Kilotons) Forecast by Application
11.2.2 Global Iguratimod Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Iguratimod Market Size Comparison by Region (M USD)
Table 5. Global Iguratimod Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Iguratimod Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Iguratimod Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Iguratimod Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iguratimod as of 2022)
Table 10. Global Market Iguratimod Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Iguratimod Sales Sites and Area Served
Table 12. Manufacturers Iguratimod Product Type
Table 13. Global Iguratimod Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Iguratimod
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Iguratimod Market Challenges
Table 22. Global Iguratimod Sales by Type (Kilotons)
Table 23. Global Iguratimod Market Size by Type (M USD)
Table 24. Global Iguratimod Sales (Kilotons) by Type (2019-2024)
Table 25. Global Iguratimod Sales Market Share by Type (2019-2024)
Table 26. Global Iguratimod Market Size (M USD) by Type (2019-2024)
Table 27. Global Iguratimod Market Size Share by Type (2019-2024)
Table 28. Global Iguratimod Price (USD/Ton) by Type (2019-2024)
Table 29. Global Iguratimod Sales (Kilotons) by Application
Table 30. Global Iguratimod Market Size by Application
Table 31. Global Iguratimod Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Iguratimod Sales Market Share by Application (2019-2024)
Table 33. Global Iguratimod Sales by Application (2019-2024) & (M USD)
Table 34. Global Iguratimod Market Share by Application (2019-2024)
Table 35. Global Iguratimod Sales Growth Rate by Application (2019-2024)
Table 36. Global Iguratimod Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Iguratimod Sales Market Share by Region (2019-2024)
Table 38. North America Iguratimod Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Iguratimod Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Iguratimod Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Iguratimod Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Iguratimod Sales by Region (2019-2024) & (Kilotons)
Table 43. Simcere Pharmaceutical Iguratimod Basic Information
Table 44. Simcere Pharmaceutical Iguratimod Product Overview
Table 45. Simcere Pharmaceutical Iguratimod Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Simcere Pharmaceutical Business Overview
Table 47. Simcere Pharmaceutical Iguratimod SWOT Analysis
Table 48. Simcere Pharmaceutical Recent Developments
Table 49. Toyama Chemical Iguratimod Basic Information
Table 50. Toyama Chemical Iguratimod Product Overview
Table 51. Toyama Chemical Iguratimod Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Toyama Chemical Business Overview
Table 53. Toyama Chemical Iguratimod SWOT Analysis
Table 54. Toyama Chemical Recent Developments
Table 55. Eisai Iguratimod Basic Information
Table 56. Eisai Iguratimod Product Overview
Table 57. Eisai Iguratimod Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eisai Iguratimod SWOT Analysis
Table 59. Eisai Business Overview
Table 60. Eisai Recent Developments
Table 61. Global Iguratimod Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Global Iguratimod Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. North America Iguratimod Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. North America Iguratimod Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Europe Iguratimod Sales Forecast by Country (2025-2030) & (Kilotons)
Table 66. Europe Iguratimod Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Asia Pacific Iguratimod Sales Forecast by Region (2025-2030) & (Kilotons)
Table 68. Asia Pacific Iguratimod Market Size Forecast by Region (2025-2030) & (M USD)
Table 69. South America Iguratimod Sales Forecast by Country (2025-2030) & (Kilotons)
Table 70. South America Iguratimod Market Size Forecast by Country (2025-2030) & (M USD)
Table 71. Middle East and Africa Iguratimod Consumption Forecast by Country (2025-2030) & (Units)
Table 72. Middle East and Africa Iguratimod Market Size Forecast by Country (2025-2030) & (M USD)
Table 73. Global Iguratimod Sales Forecast by Type (2025-2030) & (Kilotons)
Table 74. Global Iguratimod Market Size Forecast by Type (2025-2030) & (M USD)
Table 75. Global Iguratimod Price Forecast by Type (2025-2030) & (USD/Ton)
Table 76. Global Iguratimod Sales (Kilotons) Forecast by Application (2025-2030)
Table 77. Global Iguratimod Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Iguratimod
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Iguratimod Market Size (M USD), 2019-2030
Figure 5. Global Iguratimod Market Size (M USD) (2019-2030)
Figure 6. Global Iguratimod Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Iguratimod Market Size by Country (M USD)
Figure 11. Iguratimod Sales Share by Manufacturers in 2023
Figure 12. Global Iguratimod Revenue Share by Manufacturers in 2023
Figure 13. Iguratimod Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Iguratimod Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Iguratimod Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Iguratimod Market Share by Type
Figure 18. Sales Market Share of Iguratimod by Type (2019-2024)
Figure 19. Sales Market Share of Iguratimod by Type in 2023
Figure 20. Market Size Share of Iguratimod by Type (2019-2024)
Figure 21. Market Size Market Share of Iguratimod by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Iguratimod Market Share by Application
Figure 24. Global Iguratimod Sales Market Share by Application (2019-2024)
Figure 25. Global Iguratimod Sales Market Share by Application in 2023
Figure 26. Global Iguratimod Market Share by Application (2019-2024)
Figure 27. Global Iguratimod Market Share by Application in 2023
Figure 28. Global Iguratimod Sales Growth Rate by Application (2019-2024)
Figure 29. Global Iguratimod Sales Market Share by Region (2019-2024)
Figure 30. North America Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Iguratimod Sales Market Share by Country in 2023
Figure 32. U.S. Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Iguratimod Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Iguratimod Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Iguratimod Sales Market Share by Country in 2023
Figure 37. Germany Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Iguratimod Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Iguratimod Sales Market Share by Region in 2023
Figure 44. China Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Iguratimod Sales and Growth Rate (Kilotons)
Figure 50. South America Iguratimod Sales Market Share by Country in 2023
Figure 51. Brazil Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Iguratimod Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Iguratimod Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Iguratimod Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Iguratimod Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Iguratimod Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Iguratimod Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Iguratimod Market Share Forecast by Type (2025-2030)
Figure 65. Global Iguratimod Sales Forecast by Application (2025-2030)
Figure 66. Global Iguratimod Market Share Forecast by Application (2025-2030)
